|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2008-3-17
|
|
pubmed:abstractText |
The D'Amico risk group classification was originally developed to estimate the risk of biochemical recurrence following treatment for localized prostate cancer. We externally validated the ability of the risk groups to predict clinical progression, and cancer specific and overall survival following radical prostatectomy, and identify predictors of outcome in patients with high risk disease.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1527-3792
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
179
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1354-60; discussion 1360-1
|
|
pubmed:meshHeading |
pubmed-meshheading:18289596-Aged,
pubmed-meshheading:18289596-Disease Progression,
pubmed-meshheading:18289596-Humans,
pubmed-meshheading:18289596-Male,
pubmed-meshheading:18289596-Middle Aged,
pubmed-meshheading:18289596-Prognosis,
pubmed-meshheading:18289596-Prostatectomy,
pubmed-meshheading:18289596-Prostatic Neoplasms,
pubmed-meshheading:18289596-Retrospective Studies,
pubmed-meshheading:18289596-Risk Factors,
pubmed-meshheading:18289596-Severity of Illness Index,
pubmed-meshheading:18289596-Survival Analysis,
pubmed-meshheading:18289596-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Mayo Clinic validation of the D'amico risk group classification for predicting survival following radical prostatectomy.
|
|
pubmed:affiliation |
Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota, USA.
|
|
pubmed:publicationType |
Journal Article,
Validation Studies
|
